These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2919553)

  • 21. The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril.
    Macdonald NJ; Sioufi A; Howie CA; Wade JR; Elliott HL
    Br J Clin Pharmacol; 1993 Sep; 36(3):205-9. PubMed ID: 9114905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benazeprilat disposition and effect in dogs revisited with a pharmacokinetic/pharmacodynamic modeling approach.
    Toutain PL; Lefebvre HP; King JN
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1087-93. PubMed ID: 10688627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition of [14C]-benazepril hydrochloride in rat, dog and baboon. Absorption, distribution, kinetics, biotransformation and excretion.
    Waldmeier F; Schmid K
    Arzneimittelforschung; 1989 Jan; 39(1):62-7. PubMed ID: 2719745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison in young and elderly subjects of the pharmacokinetics and pharmacodynamics of single and multiple doses of benazepril.
    Macdonald NJ; Elliott HL; Hughes DM; Reid JL
    Br J Clin Pharmacol; 1993 Sep; 36(3):201-4. PubMed ID: 9114904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of benazepril for advanced chronic renal insufficiency.
    Hou FF; Zhang X; Zhang GH; Xie D; Chen PY; Zhang WR; Jiang JP; Liang M; Wang GB; Liu ZR; Geng RW
    N Engl J Med; 2006 Jan; 354(2):131-40. PubMed ID: 16407508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic/Pharmacodynamic Modeling of Renin-Angiotensin Aldosterone Biomarkers Following Angiotensin-Converting Enzyme (ACE) Inhibition Therapy with Benazepril in Dogs.
    Mochel JP; Fink M; Peyrou M; Soubret A; Giraudel JM; Danhof M
    Pharm Res; 2015 Jun; 32(6):1931-46. PubMed ID: 25446774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous determination of benazepril hydrochloride and benazeprilat in plasma by high-performance liquid chromatography/electrospray-mass spectrometry.
    Xiao W; Chen B; Yao S; Cheng Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):303-8. PubMed ID: 15639452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil.
    Muirhead GJ; Wilner K; Colburn W; Haug-Pihale G; Rouviex B
    Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):21S-30S. PubMed ID: 11879256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal actions of the new angiotensin-converting enzyme inhibitor benazepril hydrochloride.
    Levens NR
    Arch Int Pharmacodyn Ther; 1988; 296():131-43. PubMed ID: 2853611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive mechanism of action of the novel angiotensin converting enzyme inhibitor benazepril. Effect on isolated vascular preparations.
    Kuroda K; Fukuda Y; Nakao K; Inukai T
    Arzneimittelforschung; 1990 Sep; 40(9):968-73. PubMed ID: 2080946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of benazepril on contrast-induced acute kidney injury for patients with mild to moderate renal insufficiency undergoing percutaneous coronary intervention.
    Li XM; Cong HL; Li TT; He LJ; Zhou YJ
    Chin Med J (Engl); 2011 Jul; 124(14):2101-6. PubMed ID: 21933609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and Tolerability of Lorcaserin in Special Populations: Elderly Patients and Patients with Renal or Hepatic Impairment.
    Christopher RJ; Morgan ME; Tang Y; Anderson C; Sanchez M; Shanahan W
    Clin Ther; 2017 Apr; 39(4):837-848.e7. PubMed ID: 28365033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Site-differential gastrointestinal absorption of benazepril hydrochloride in healthy volunteers.
    Chan KK; Buch A; Glazer RD; John VA; Barr WH
    Pharm Res; 1994 Mar; 11(3):432-7. PubMed ID: 8008712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency.
    Hou FF; Xie D; Zhang X; Chen PY; Zhang WR; Liang M; Guo ZJ; Jiang JP
    J Am Soc Nephrol; 2007 Jun; 18(6):1889-98. PubMed ID: 17494885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection of Renal Function with ACE Inhibitors: Experience with Benazepril.
    Aldigier JC; Meur YL; Brunel P
    Clin Drug Investig; 1998; 16(6):463-72. PubMed ID: 18370561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absorption and disposition of moclobemide in patients with advanced age or reduced liver or kidney function.
    Stoeckel K; Pfefen JP; Mayersohn M; Schoerlin MP; Andressen C; Ohnhaus EE; Frey F; Guentert TW
    Acta Psychiatr Scand Suppl; 1990; 360():94-7. PubMed ID: 2248088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. General pharmacology of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride. Effects on cardiovascular, visceral and renal functions and on hemodynamics.
    Yamamoto S; Takemori E; Hasegawa Y; Kuroda K; Nakao K; Inukai T; Sakonjyo H; Nishimura T; Nishimori T
    Arzneimittelforschung; 1991 Sep; 41(9):913-23. PubMed ID: 1796919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure.
    Balfour JA; Goa KL
    Drugs; 1991 Sep; 42(3):511-39. PubMed ID: 1720384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioequivalence of a new liquid formulation of benazepril compared with the reference tablet product.
    Kelers K; Devi JL; Anderson GA; Zahra P; Vine JH; Whittem T
    Aust Vet J; 2013 Aug; 91(8):312-9. PubMed ID: 23889096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.